![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:7905L Healthcare Enterprise Group PLC 08 November 2006 8 November 2006 Healthcare Enterprise Group PLC (the "Company") Issue of shares Firm Placing Further to the announcement made on 2 November 2006, the Firm Placing (as further described in such announcement) is now complete. Accordingly 6,666,667 ordinary shares of 2.5 pence each in the Company ("Ordinary Shares") were admitted to trading on AIM this morning. Of these shares, Directors of the Company or their connected persons subscribed for 3,333,333 Ordinary Shares at 3 pence per share as follows: Mr Lyndon Gaborit - 833,333 Mr Mark Tompkins - 833,333 Mr Nigel Wray - 1,666,667. Non-Executive Directors Share Issues In addition, in relation to the provision of services as non-executive directors, the Company has allotted Ordinary Shares on 8 November 2006 (at the mid-market closing price on 7 November 2006 of 3.38p per share) in satisfaction of professional fees as follows: Mr Nicholas Brigstocke - 133,136 Ordinary Shares in the Company (at 3.38p per share); Mr Mark Tompkins - 133,136 Ordinary Shares in the Company (at 3.38p per share); and Mr Nigel Wray - 133,136 Ordinary Shares in the Company (at 3.38p per share). The shares are expected to be admitted to trading on AIM on 15 November 2006. Exercise of Options In addition, the Company announces that a total of 1,520,681 new Ordinary Shares have been issued and allotted, pursuant to the Company's share option scheme, on 8 November 2006. The optionholders exercising options were as follows: Mr Nicholas Brigstocke (a non-executive director of the Company) - 113,246 Ordinary Shares in the Company (at 2.5p per share); Mr Ken Denos (formerly an executive director of the Company) - 199,476 Ordinary Shares in the Company (at 2.5p per share); and Mr Michael Low (formerly an executive director of the Company) - 1,207,959 Ordinary Shares in the Company (at 2.5p per share). The shares are expected to be admitted to trading on AIM on 15 November 2006. Directors' Shareholdings The resulting holdings of the Directors are as follows: Director Overall Number of Percentage of issued share capital as enlarged number of new Ordinary Shares by the Placing (assuming the shareholder Ordinary held following resolutions at the EGM on 27 November are Shares the Placing and passed and the Conditional Placing Shares, as acquired shares issues further described in the 2 November notified in this announcement, are all allotted) announcement Nicholas Brigstocke 246,382 2,072,186 0.76 Lyndon Gaborit 833,333 1,053,351 0.38 Mark Tompkins 966,469 1,274,409 0.47 Nigel Wray 1,799,803 17,222,057 6.32 Total 3,845,987 21,622,003 7.93 Fertiloscopy Further to previous announcements about the restructuring and scaling back on capital expenditure, the Group's decision not to proceed with the Fertiloscopy project has resulted in the issue, on 8 November 2006, of 1,008,428 ordinary shares of 2.5p each in the Company in respect of the closure of matters relating to Fertiloscopy, at a (five preceding days mid-market closing) price of 3.322 pence per share. The shares are expected to be admitted to trading on AIM on 15 November 2006. Total Issued Share Capital The Company's issued share capital at this time is 212,483,387 ordinary shares of 2.5 pence each. Conditional Placing and amendment to warrant terms As set out in the announcement on 2 November 2006, a further 60,000,000 ordinary shares have been placed on a conditional basis. Subsequent to that, the issued share capital of the Company (subject to any further allotments) would be 272,483,387 Ordinary Shares. The conditions include, among other things, the passing by shareholders at an EGM to be held on 27 November 2006 of a resolution to give the Directors authority to allot shares up to an agreed limit and to dis-apply statutory pre-emption rights on allotments of shares. As further described in the 2 November announcement, subject to the passing of resolutions at the EGM and warrantholders meeting on 27 November, the Company will allot warrants (on a 1 for 4 basis) to placees under the Placing, and amend the terms of the existing warrants in issue. Enquiries: College Hill 020 7457 2020 Adrian Duffield / Corinna Dorward This information is provided by RNS The company news service from the London Stock Exchange END IOEDVLFBQFBEFBE
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions